{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ00533",
      "entity_text" : "soluble E-cad",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-0114" ],
      "Cellular_component" : [ "go:GO:0031012" ],
      "Organ" : [ "uberon:UBERON:0000105" ],
      "Species" : [ "taxonomy:9606" ]
    }
  },
  "verbose_text" : "Gogali et al. found that serum levels of E-cad were significantly elevated in patients with non small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) compared with healthy controls, and serum soluble E-cad levels were correlated with presence of distant metastasis in patients with SCLC and NSCLC, suggesting that E-cad may have prognostic value [XREF_BIBR].",
  "reading_complete" : "2020-08-04T11:59:02Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T11:56:00Z",
  "trigger" : "levels",
  "evidence" : [ "soluble E-cad levels" ],
  "pmc_id" : "4280058",
  "score" : 0
}